MicroRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4  Julia C. Eggers, Valentina.

Slides:



Advertisements
Similar presentations
Volume 342, Issue 1, Pages (January 2014)
Advertisements

Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
Volume 355, Issue 2, Pages (December 2014)
M. Louise Hull, Victoria Nisenblat  Reproductive BioMedicine Online 
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Kam-Hei So, Cheuk-Lun Lee, William S.B. Yeung, Kai-Fai Lee 
a b SUM149PT Motility Invasion C V C V
MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells  Mi Zhang, MD, Xiaohong Liu, MD, Xiwu Zhang, MD, Zhigang Song, MD, Lin Han,
M. Louise Hull, Victoria Nisenblat  Reproductive BioMedicine Online 
Volume 133, Issue 2, Pages (August 2007)
MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration  Dongqing Li, X.I. Li, Aoxue Wang, Florian Meisgen, Andor.
Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and.
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Expression of KRAS in the endometrium of early pregnant mice and its effect during embryo implantation  Xia Long, Min Zhang, Xuemei Chen, Junlin He, Yubin.
MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements.
Anca Chelariu-Raicu, M. D. , Cornelia Wilke, Ph. D. , Melanie Brand, M
Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells  Fereshteh Karimzadeh,
L. Aghajanova, L.C. Giudice  Reproductive BioMedicine Online 
Volume 137, Issue 2, Pages e2 (August 2009)
Altered microRNA expression in stenoses of native arteriovenous fistulas in hemodialysis patients  Lei Lv, MD, Weibin Huang, MD, Jiwei Zhang, MD, Yaxue.
Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade  Florian Rambow, Audrey Bechadergue, Flavie Luciani, Gwendoline Gros, Melanie.
Identification of miR-145 as a Key Regulator of the Pigmentary Process
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 47, Issue 2, Pages (July 2012)
Knockdown of prohibitin expression promotes glucose metabolism in eutopic endometrial stromal cells from women with endometriosis  Xiaochen Qi, Yanxin.
Regulating Cancer Stem Cells the miR Way
MiR-142-3p is a novel regulator of cell viability and proinflammatory signalling in endometrial stroma cells  Christin Susanna Kästingschäfer, Sebastian.
Volume 136, Issue 2, Pages (February 2009)
Volume 7, Issue 1, Pages e7 (July 2018)
Volume 135, Issue 1, Pages (July 2008)
Volume 8, Issue 4, Pages (April 2017)
Volume 152, Issue 1, Pages (January 2019)
Volume 22, Issue 10, Pages (October 2014)
Molecular Therapy - Nucleic Acids
Sana M. Salih, M. D. , Salama A. Salama, Ph. D. , Amin A. Fadl, Ph. D
Volume 25, Issue 3, Pages (March 2017)
MiR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53 by Francisco Navarro, David Gutman, Eti Meire, Mario Cáceres,
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 23, Issue 10, Pages (October 2016)
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis  Anping Lin, Juan Yin, Chao.
Laura S. Bisogno, Matthew B. Friedersdorf, Jack D. Keene
Volume 7, Issue 2, Pages (August 2016)
Myeloma cell–derived Runx2 promotes myeloma progression in bone
Volume 9, Issue 5, Pages (November 2017)
Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage  F. Wei, J. Zhou, X. Wei,
Volume 138, Issue 4, Pages (April 2010)
Volume 21, Issue 1, Pages (January 2011)
Volume 21, Issue 9, Pages (November 2017)
Volume 18, Issue 6, Pages (December 2015)
Volume 127, Issue 4, Pages (October 2004)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 7, Issue 5, Pages (November 2010)
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 6, Issue 3, Pages (March 2016)
Volume 9, Issue 5, Pages (November 2017)
Jui-Hung Chang, Ph. D. , Heng-Kien Au, M. D. , Wei-Chin Lee, M. S
Protein Kinase C-Dependent Upregulation of miR-203 Induces the Differentiation of Human Keratinocytes  Enikö Sonkoly, Tianling Wei, Elizabeth Pavez Loriè,
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
Molecular Therapy - Nucleic Acids
Volume 4, Issue 4, Pages (April 2015)
Volume 24, Issue 10, Pages (October 2016)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Presentation transcript:

microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4  Julia C. Eggers, Valentina Martino, Rolland Reinbold, Sebastian D. Schäfer, Ludwig Kiesel, Anna Starzinski-Powitz, Andreas N. Schüring, Björn Kemper, Burkhard Greve, Martin Götte  Reproductive BioMedicine Online  Volume 32, Issue 4, Pages 434-445 (April 2016) DOI: 10.1016/j.rbmo.2015.12.013 Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Up-regulation of miR-200b in 12Z and primary patient cells represses the expression of the EMT-associated transcription factors ZEB1 and ZEB2. (A) Bioinformatic analysis by the miRanda algorithm (John et al., 2004) identifies ZEB1 and ZEB2 as predicted targets of human miR-200b (hsa-miR-200b). Shown is an alignment of one of the 5/6 (ZEB1/ZEB2) predicted binding sites of the miR-200b seed sequence to the respective target mRNAs. Alignment data are taken from the microRNA.org database (Betel et al., 2008). (B) qPCR analysis of 12Z cells transfected with miR-200b precursors or a scrambled control microRNA reveals a significant miR-200b up-regulation relative to controls. * = P < 0.01, error bars = SEM, n = 6. (C) 12Z and primary patient cells were transfected with either miR-200b precursors or a scrambled microRNA as a control. qPCR analysis reveals that ZEB1 and ZEB2 expression decrease significantly following pre-miR-200b overexpression in 12Z cells (ZEB1: * = P < 0.026, ZEB2: ** = P < 0.009) and in primary cells (ZEB1: *** = P < 0.0001, ZEB2: *** = P < 0.0001). Statistical analysis was performed separately for 12Z and primary cells, whereas only one graphical representation for control concentration is shown (fold change = 1). Error bars = SEM, n = 3. Reproductive BioMedicine Online 2016 32, 434-445DOI: (10.1016/j.rbmo.2015.12.013) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 miR-200b induces an up-regulation of E-cadherin in endometriotic cells. Expression of E-cadherin was determined by quantitative real-time-PCR (A) or western blotting (B,C) after transfection of miR-200b precursors, using a scrambled microRNA as a control. (A) Compared with the controls, E-cadherin expression increases in both the endometrial cell line 12Z and in primary patient cells due to pre-miR-200b overexpression (** = P < 0.002 in 12Z, *** = P < 0.001 in primary cells, error bars = SD, n = 3 (12Z) / n = 9 (primary cells)]. Statistical analysis was performed separately for 12Z and primary cells, whereas only one graphical representation for control concentrations is shown (fold change = 1). (B,C) Western blot analysis revealed an increased expression of E-cadherin also at the protein level in 12Z cells. (B) Representative image of two independent biological replicates of control- and miR-200b transfected 12Z cells. (C) Data of three independent experiments were normalized to tubulin expression and quantified by densitometry (error bars = SEM, n = 3; ** = P < 0.001). Reproductive BioMedicine Online 2016 32, 434-445DOI: (10.1016/j.rbmo.2015.12.013) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 3 Up-regulation of miR-200b decreases endometriotic cell invasiveness. 12Z cells were transfected with either miR-200b precursors or scrambled micro-RNA as a control. Cell invasiveness was measured, comparing the numbers of cells penetrating matrigel-invasion chamber filters towards a gradient of fetal calf serum. Fewer cells of the miR-200b treated group invaded the lower chamber (*** = P < 0.0001, n = 12, error bars = SEM), indicating a decreased invasiveness. (A) Quantitative analysis. (B) Representative images of matrigel invasion filter. Scale bar = 250 µm. Reproductive BioMedicine Online 2016 32, 434-445DOI: (10.1016/j.rbmo.2015.12.013) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 4 Investigation of the impact of miR-200b on endometrial stroma cell motility by digital-holographic video microscopy. For evaluation of motility, ST-T1b cells were tracked using automated cell tracking in sequences of quantitative digital-holographic phase contrast images. Up-regulation of miR-200b results in decreased cell motility. (A) Representative migration tracks of control miRNA-transfected (left panel, n = 30) and miR-200b-transfected (right panel, n = 30) ST-T1b cells. (B) Mean squared displacement of control miRNA- (green) and miR-200b-transfected (red) ST-T1b cells. One line represents the mean of 8–12 individual cells of one experiment. Three independent experiments are shown. (C) Quantitative analysis of the maximal migration distance from the starting point reveals a reduced migration distance in miR-200b transfected cells compared with controls (* = P < 0.016, n = 30, error bars = SEM). Reproductive BioMedicine Online 2016 32, 434-445DOI: (10.1016/j.rbmo.2015.12.013) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 5 Up-regulation of miR-200b increases the expression of the pluripotency-associated transcription factor KLF4, enhances the side population phenotype, and promotes cell proliferation. (A) Expression of KLF4, OCT4 and SOX2 were determined by qPCR after transfection of 12Z and primary endometriotic stroma cells (prim) with miR-200b precursors. A scrambled micro-RNA was used as a control. Compared with the controls, KLF4 expression increased in both the endometrial cell line 12Z and in primary patient cells following pre-miR-200b overexpression (*** = P < 0.0001 in 12Z, * = P < 0.015 in primary cells). There was no significant effect on OCT4 and SOX2 expression. The insert shows the predicted miR-200b binding site within the KLF4 mRNA (see Figure 1A for details). (B) Flow cytometry reveals an increased side population (SP), a surrogate stem cell marker, after miR-200b transfection of 12Z cells. SP cells become visible in gate R2. In the representative example shown, cells were treated with verapamil to inhibit ABC-transporters, resulting in an SP proportion of 0.29% (left panel). Control pre-miR-treated cells show 1.0% of cells in the SP (central panel), which increased to 2.35% in the pre-miR-200b sample (right panel). (C) Quantitative analysis of the miR-200b-induced changes in the SP phenotype in 12Z cells (** = P < 0.01, n = 3, error bars = SEM). (D) Up-regulation of miR-200b enhances cell proliferation. 12Z cells were transfected with either miR-200b or scrambled micro-RNA as a control. Cell proliferation was measured by flow cytometry applying a BrdU staining protocol. After transfection, cells incorporated more BrdU, reflecting an increased DNA synthesis (*** = P < 0.0001, n = 7, Error bars = SEM). Reproductive BioMedicine Online 2016 32, 434-445DOI: (10.1016/j.rbmo.2015.12.013) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

Figure 6 miR-200b as a regulator of invasive growth, cell motility and proliferation in endometriosis. Model of miR-200b function based on the data of this study and literature data. miR-200b is down-regulated in endometriotic tissue compared with eutopic and healthy endometrium (Filigheddu et al., 2010; Hawkins et al., 2011; Ohlsson Teague et al., 2009). This down-regulation results in increased expression of its target mRNAs ZEB1 and ZEB2, resulting in a transcriptional down-regulation of E-cadherin expression, which is repressed by ZEB1/2. A low expression of E-cadherin corresponds to increased invasive behaviour of endometriotic cells. In addition, the down-regulation of miR-200b in endometriosis is associated with a reduction on KLF4 expression. In some tumour entities, this reduction corresponds to increased invasive growth (Choi et al., 2006; Wei et al., 2005), whereas KLF4 affects proliferation and stemness when acting in concert with additional transcription factors (SOX2, OCT4, c-MYC) (Adammek et al., 2013; Yamanaka, 2013). See text for additional details. Reproductive BioMedicine Online 2016 32, 434-445DOI: (10.1016/j.rbmo.2015.12.013) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions